Brief: AN2 Therapeutics Signs Grant Agreement To Discover Novel, Boron Based Therapies For Tuberculosis And Malaria
26/09/2023 12:35
Sept 26 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS SIGNS GRANT AGREEMENT TO DISCOVER NOVEL,
BORON
BASED THERAPIES FOR TUBERCULOSIS AND MALARIA
Source text for Eikon: ID:nBwxX4R1a
Further company coverage: ANTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview